Novo Nordisk’s Wegovy cuts risk of heart attack and stroke by 20% among people without diabetes, study finds
November 11, 2023 at 08:47 AM EST
Closely watched clinical trial could help boost insurance coverage of GLP-1 drugs, analysts say.
